-
Six Sigma Deployment For Complete Package Quality Control Upcoming Presentation During HealthPack 2012
2/8/2012
Oliver Stauffer of PTI Inspection Systems will give a presentation on "Six Sigma Deployment for Complete Package Quality Control" during the HealthPack Conference for Medical Device Packaging in Albuquerque, New Mexico, March 6-8, 2012 at the Hyatt Regency.
-
TSI Announces New Remote Particle Counters With 4-20 mA Analog Outputs
2/8/2012
TSI Incorporated is pleased to announce a new range of Remote Particle Counters with 4-20 mA Analog Outputs.
-
Eriez® High Deflection (HD) Series Feeders Handle Practically Any Bulk Material
2/8/2012
Eriez® High Deflection (HD) Series Feeders are designed to handle products that normally can't be fed successfully on an electromagnetic feeder. Their totally enclosed patented magnetic drive enables feeding of practically any bulk material from micron size to bulky chunks.
-
Safe Evaporation Of Diethyl Ether Assists Lipid Extractions
2/8/2012
The Inert Gas Purge (IGP) system, available for use with most Genevac evaporators, enables safe operation even when working with highly explosive solvents, those with a low flash point, very low auto-ignition temperature and a wide explosive vapour saturation range.
-
Brooks Life Science Systems And The Scripps Research Institute Initiate Partnership
2/8/2012
Brooks Life Science Systems, a division of Brooks Automation, Inc., a leading worldwide provider of automation solutions for compound and biological sample storage and management, recently announced the initiation of a technology development and commercialization partnership with The Scripps Research Institute (Scripps Research).
-
Watson Provides Update On Generic Lidoderm® Application
2/8/2012
In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm® patent challenge, Watson Pharmaceuticals, Inc. (NYSE: WPI) today issued the following statement:
-
Valeant Pharmaceuticals Completes Divestiture Of Generic Dermatology Products To Mylan
2/8/2012
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc. (Nasdaq: MYL).
-
Siemens Forms New Companion Diagnostics Partnerships With ViiV Healthcare And Tocagen
2/8/2012
Siemens Healthcare Diagnostics announces two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen — marking a major step for Siemens (NYSE: SI) into this important and fast-growing segment of the in vitro diagnostics (IVD) market.
-
Merck Announces Top-Line Results Of TRA-2P Study Of Vorapaxar
2/7/2012
Merck, known outside the United States and Canada as MSD, recently announced the top-line results of the TRA-2P (Thrombin Receptor Antagonist in Secondary Prevention of atherothrombotic ischemic events) study of vorapaxar.
-
China Emerging As An Innovation Hub For Formulation And Delivery
2/7/2012
A clutch of promising Chinese companies in the formulation and delivery (F/D) market underlines the emergence of the Asian giant as a center for biopharma innovation and entrepreneurship, even as Western pharmaceutical companies continue to enjoy technological and business advantages, according to a Lux Research report titled, "The Expanding Formulation and Delivery Market in China."
